SeaStar Medical Holding SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

  • Kevin Chung

Press/Media

Period13 Mar 2024

Media coverage

1

Media coverage

  • TitleSeaStar Medical Holding SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date13/03/24
    PersonsKevin Chung